1511P The demographics of cancer care in a developing country: ten years’ experience from an academic university hospital in India

Abstract

Background: Despite the efforts of scientific organisations, patients' views of immunotherapy are unclear. CareAcross, a multilingual digital platform which provides personalised, evidence-based support to cancer patients, investigated their views on immunotherapy.

The Cancer Treatment Gap in Lower- to Middle-Income Countries

“…In addition, the circumstances of the patients presenting to cancer facilities can also contribute to the observed disparities. For example, a recent study in India found that oncology patients presented at a younger median age, had lower levels of education, were more likely to be financially distressed, and had to travel greater distances to seek specialized treatment [6] . Cost of care is one of the main barriers to patient treatment.…”

“…A systematic review and meta-analysis by Donkor et al [3] (2022) found that patients in LMICs experience high levels of financial toxicity. Such financial and logistical considerations are often not factored into guidelines, particularly those developed in countries with a high human development index [6] .…”